公司資料
Takeda 股價、新聞與催化劑
- 股票代碼:
- TAK
- 交易所:
- NYSE
- 產業:
- Biopharma
- 所在地:
- Japan and listed in the U
股票表現
17.38 USD (-1.42%)
收盤價
最後更新: 2026年8月17日
48B USD
市值
股價為何變動
As of Aug 17, 2026, TAK closed down 1.42% at $17.38. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Takeda is a global pharmaceutical company with broad exposure to gastroenterology, oncology, rare disease, plasma-derived therapies, and vaccines. Its business is defined by scale, diversification, and a strong international footprint.
所在地與產業分類
Takeda is headquartered in Japan and listed in the U.S. market. It sits in global large-cap pharma rather than biotech.
商業模式特徵
The company generates value through branded medicines, portfolio diversification, and disciplined R&D reinvestment. Investors watch pipeline progress, earnings stability, and geographic breadth.
生技產業定位
Takeda sits in the top tier of global pharma. It is less binary than biotech, but its pipeline and launch cadence still matter to the market.
未來催化劑
- Takeda’s catalysts are oncology, rare disease, and GI portfolio execution, plus any pipeline update that helps the growth mix evolve. The company will be watched for broad commercial stability.
近期新聞
- 01
- 02
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。